Company intelligence / Profile preview

TAMASERV

Ownership: Private
Development stage: Other

Overview

TAMASERV provides advanced analytical services for the qualitative and quantitative analysis of RNA and DNA modifications. Their expertise supports international researchers in epigenetics, epitranscriptomics, and the development of RNA-based therapeutics by offering precise measurement of nucleoside modifications relevant to both basic research and applied fields such as vaccine stability.

Therapeutic areas: Other
Modalities: Nucleic acid analysis (RNA, DNA modifications)RNA analytics for therapeutics and vaccines
Industry: Drug Discovery Services

Partnerships

Collaborates with international academic researchersPartners in agricultural projects applying RNA modification analytics to crop yield/resilience

Beyond the preview

Go deeper on TAMASERV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAMASERV.

Explore the full profile